W. Mullally
Direktor/Vorstandsmitglied bei THIOGENESIS THERAPEUTICS, CORP.
Vermögen: 448 875 $ am 31.05.2024
Profil
W.
Hogan Mullally is the founder of Sectorspeak, Inc. (founded in 2008) where he holds the title of President.
He is currently working as a Director at Thiogenesis Therapeutics, Inc. and as an Independent Director at Thiogenesis Therapeutics Corp.
He has previously worked as a Director-Investor Relations at Medicure, Inc. (2005-2008), as a Director at Rozdil Capital Corp., as a Vice President-Investor Relations at Functional Technologies Corp.
(2008-2012), and as the Head-Pharmaceutical Sales & Marketing at Bausch & Lomb (Australia) Pty Ltd.
(1999-2001).
Mr. Mullally holds an MBA from Asper School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.08.2023 | 875 000 ( 2,10% ) | 448 875 $ | 31.05.2024 |
Aktive Positionen von W. Mullally
| Unternehmen | Position | Beginn |
|---|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Direktor/Vorstandsmitglied | 03.05.2018 |
| Sectorspeak, Inc. | Gründer | 01.03.2008 |
Ehemalige bekannte Positionen von W. Mullally
| Unternehmen | Position | Ende |
|---|---|---|
| ROZDIL CAPITAL CORPORATION | Direktor/Vorstandsmitglied | 18.04.2022 |
| MEDICURE INC. | Public Communications Contact | 01.01.2008 |
Bausch & Lomb (Australia) Pty Ltd.
 Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Vertrieb & Marketing | 01.01.2001 |
| FUNCTIONAL TECHNOLOGIES CORP | Investor Relations Kontakt | - |
Ausbildung von W. Mullally
| Asper School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| THIOGENESIS THERAPEUTICS, CORP. | Finance |
| MEDICURE INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Rozdil Capital Corp.
 Rozdil Capital Corp. Financial ConglomeratesFinance Rozdil Capital Corp. operates as a capital pool company. It is engaged in the identification and evaluation of assets or businesses with a view to completing a Qualifying Transaction. The company was founded on May 3, 2018 and is headquartered in Toronto, Canada. | Finance |
| Sectorspeak, Inc. | |
Functional Technologies Corp.
 Functional Technologies Corp. Food: Major DiversifiedConsumer Non-Durables Functional Technologies Corp. develops and commercializes proprietary, yeast-based solutions in the food, beverage and healthcare industries. Its technologies include yeasts that prevent and reduce the formation of foul-smelling hydrogen sulphide and carcinogen and acrylamide, both by-products of food and beverage processing. The company was founded by Howard J. Louie and Geoffrey Conrad Lee on October 18, 1999 and is headquartered in Vancouver, Canada. | Consumer Non-Durables |
Bausch & Lomb (Australia) Pty Ltd.
Bausch & Lomb (Australia) Pty Ltd. Pharmaceuticals: MajorHealth Technology Bausch & Lomb Australia Pty Ltd. manufactures and distributes prescription medicines. It offers consumer healthcare, prescription, aesthetic skin and eyecare. The company was founded in 2006 and is headquartered in Chatswood, Australia. | Health Technology |
